Reksod® (Rexod®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceSuperoxide dismutaseSuperoxide dismutase
Similar drugsTo uncover
  • Reksod®
    lyophilizate in / in 
    GosNII OCHB FMBA, FSUE     Russia
  • Reksod®
    solution in / in 
    GosNII OCHB FMBA, FSUE     Russia
  • Рексод®-ОФ
    lyophilizate d / eye 
    GosNII OCHB FMBA, FSUE     Russia
    • Dosage form: & nbspsolution for intravenous administration
    ATX: & nbsp

    S.01.X   Other drugs for the treatment of eye diseases

    Terms of leave from pharmacies:On prescription
    Registration number:LP-004754
    Date of registration:26.03.2018
    Expiration Date:26.03.2023
    The owner of the registration certificate:GosNII OCHB FMBA, FSUE GosNII OCHB FMBA, FSUE Russia
    Manufacturer: & nbsp
    Information update date: & nbsp24.04.2018
    Illustrated instructions
      Instructions
      Up